卵巢癌患者就医出行距离与医院手术量对短期和长期结局的影响
基于美国国家癌症数据库2004至2016年确诊并接受初次手术的56834例II-IV期上皮性卵巢癌患者,研究出行距离与短期及长期结局的关联。倾向评分加权后,远距离就医(Q4 vs Q1)患者90天死亡率显著更低;与短途至低手术量中心者相比,远途至高手术量医院者30天再入院率降低,但30天、90天及5年死亡率无差异。西班牙裔和黑人女性及医疗补助参保者远距离就医的可能性更低。
要点
- 远距离就医与90天死亡率降低相关,但30天、90天及5年死亡率与短途至低手术量中心者无差异。
- 远途至高手术量医院者30天再入院率低于短途至低手术量中心者。
- 西班牙裔、黑人女性及医疗补助参保者远距离就医的可能性更低。
核心结论
- 卵巢癌手术的出行距离随时间增加,远距离就医可能有短期获益,但长期结局差异很小。
研究设计与样本
- 回顾性队列研究,纳入美国国家癌症数据库2004至2016年确诊并接受初次手术的56834例II-IV期上皮性卵巢癌患者,治疗于1201家医院。
- 采用混合效应对数线性模型和比例风险模型,经倾向评分加权分析出行距离与短期及长期结局的关联。
- 进一步比较短途至低手术量中心(Local组)与远途至高手术量医院(Travel组)的患者。
主要发现
- 西班牙裔女性远距离就医至最大距离四分位中心的可能比白人女性低58%,黑人女性低64%。
- 医疗补助参保者相比商业保险者,远距离就医至第四四分位医院的可能性更低。
- 远距离就医(Q4 vs Q1)患者90天死亡率显著更低(P < 0.0001)。
- Travel组相比Local组30天再入院率降低。
- Local组与Travel组在30天、90天或5年死亡率上无差异。
临床怎么用
- 对于卵巢癌初次手术,可考虑将患者转诊至区域中心以可能降低短期不良结局,但需权衡长期结局无显著差异及出行负担。
- 关注西班牙裔、黑人女性及医疗补助参保者远距离就医障碍,促进公平可及的专科手术资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine patterns of patient travel among women with ovarian cancer and to explore the association between travel distance and short and long-term outcomes. METHODS: Women with stage II-IV epithelial ovarian cancer diagnosed from 2004 to 2016 who underwent primary surgery were identified in the National Cancer Database. Mixed-effect log-linear models and proportional hazards models were developed to evaluate the association between travel distance and short and long-term outcomes after propensity score weighting. A further analysis was performed to compare patients who traveled a short distance to a low volume center (Local) to patients who traveled farther to a high volume hospital (Travel). RESULTS: We identified 56,834 patients treated in 1201 hospitals. Hispanic women were 58% and black women 64% less likely than white women to travel to a center in the greatest distance quartile for care. Similarly, Medicaid recipients (vs. commercially insured) were less likely to travel to a quartile four hospital (compared to Q1 of distance traveled). Of all patients, 90-day mortality was significantly lower in patients who traveled farther (Q4 vs. Q1; P < 0.0001). Compared to women in the Local group, patients in the Travel group had a decreased 30-day readmission rate. There was no difference in 30-day, 90-day, or 5-year mortality when comparing the Local to the Travel group. CONCLUSIONS: Travel distance for ovarian cancer surgery has increased over time. While there may be some short-term benefits in traveling to a regional center for care, there was little difference in long term outcomes based on travel distance.
引用
- Knisely A, Huang Y, Melamed A, et al. Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes. Gynecol Oncol. 2020. PMID: 32456990. doi:10.1016/j.ygyno.2020.05.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。